PDF
(Download)
|
- Chamomile (Matricaria recutita syn. M. chamomilla, Asteraceae)
- Sleep Quality
- Elderly
|
Date:
04-30-2018 | HC# 011881-591
|
Re: Small Study Shows that Chamomile Extract May Increase Sleep Quality for Older Adults
Adib-Hajbaghery
M, Mousavi SN. The effects of chamomile extract on sleep quality among elderly
people: A clinical trial. Complement Ther
Med. December 2017;35:109-114.
As
people age, sleep disturbances, including insomnia, become more common, with
half of elderly adults suffering from sleep disturbances of some kind. The rate
is even higher in nursing homes, where studies have shown that 70% of residents
experience sleep disturbances. Since poor sleep can impact both physical and
psychological health, improvements in sleep quality can have important benefits
for the elderly. While most elderly people use sedative-hypnotic drugs to treat
sleep disturbances, these can have side effects that are worse than the
symptoms of the disorder itself.
Herbal
remedies provide an alternative treatment for sleep disturbances, with
chamomile (Matricaria recutita syn. M. chamomilla,
Asteraceae)
being a frequently used, well-tolerated sleep aid. In addition to its many
other uses, chamomile has traditionally been used to calm agitation, anxiety,
and sleep disturbances. Its tranquilizing effects have been attributed to
apigenin and other flavonoids that bind benzodiazepine receptors in the brain.
Despite its therapeutic effects, there is scant clinical evidence on its
effectiveness in treating human sleep disturbances. The purpose of this case
study was to evaluate the effects of chamomile on sleep disturbances in elderly
adults.
This
single-blind randomized controlled trial was conducted in the Kahrizak nursing
home in Karaj, Iran, from April to May 2016, funded by a grant from the Kashan
University of Medical Sciences (Kashan, Iran). A total of 60 patients were
selected from a study population of 195 adults living in the nursing home, age
60 and above. Patients were eligible for the trial if they scored a 5 or higher
on the Pittsburgh Sleep Quality Index (PSQI), were not allergic to chamomile or
its derivatives, were able to communicate with physicians and researchers, were
not currently taking chamomile, were not using anticoagulants, were not
dependent on any medications, and were not suffering from a list of defined
chronic conditions.
Patients
were assigned to a control or treatment group by block randomization, with 30 patients
per group. Baseline data were collected for each patient after recruitment to
the study and included a questionnaire and the PSQI. The PSQI is a standard
18-item index, which includes the following components: subjective sleep
quality; sleep latency; sleep duration; habitual sleep efficiency (total sleep
hours ÷ total hours in bed × 100); sleep disturbances; use of sleep
medications; and daytime dysfunction. Individual items on the PSQI are scored
from 0 to 3, with a total score of 5 or above indicating low sleep quality.
Chamomile
extract and wheat (Triticum aestivum,
Poaceae) flour capsules were given to the treatment and control groups,
respectively. The chamomile extract capsules were prepared by the percolation
method by first soaking the ground plant in 70% ethanol, extracting and then
vacuum-concentrating the material, and finally drying the concentrate using a spray
dryer. The dry powder was then put into capsules at a 200-mg dosage. The
control group received a 200-mg dose of wheat flour in a capsule identical to
the chamomile, except for an identifying code used by the researchers. The
capsules were manufactured and coded by Ahura Pharmaceutical Company; Shiraz,
Iran.
Patients
in both groups received the appropriate 200-mg capsule twice a day for 28
consecutive days. After the initial pre-trial assessment, patients were again
assessed for sleep quality using the PSQI 2 weeks into the trial, immediately
after completion of the trial, and 2 weeks after completion, for a total of 4
assessments. The assessments were conducted by a physician and nurse who were
not blinded to the trial, so that they could monitor any adverse reactions to
the chamomile, if they were to occur (none were reported).
Data
were analyzed via Chi-square and Fisher's exact tests, as well as
independent-sample t-test. PSQI score
variation was conducted through repeated-measures analysis of variance. All
analyses were completed with Statistical Package for the Social Sciences (SPSS)
software v13.
Of
the 60 patients, 68.3% were female, 66.7% were married, and 60% were
illiterate. The mean age of the control group was 70.73 ± 6.44, and the mean
age of the treatment group was 69.36 ± 4.99. There were no significant differences
between the 2 groups in mean age, gender, educational or marital status, or
history of chronic conditions (P>0.05 for all). While there was no
statistically significant difference in mean PSQI scores between the groups at
the start of the trial or at the 2-week assessment (P=0.639), those differences
were significant at the third (P=0.007) and final (P=0.002) assessments. Also,
there was improvement in sleep quality in the treatment group during the course
of the trial, with significant pairwise differences in all (P=0.001) but the
third and fourth assessments (P=0.99). The control group saw no such
improvement in sleep quality (P values not given). Finally, there were
significant differences between the treatment and control groups in 5 of the
PSQI components as follows: subjective sleep quality (P=0.001); sleep
disturbances (P=0.001); daytime dysfunction (P=0.013); sleep efficiency
(P=0.001); and sleep latency (P=0.008). In short, sleep quality for the
treatment group improved significantly while they were receiving the chamomile
extract capsules, and no corresponding improvement was recorded for the control
group. These findings are in agreement with other recent research on the use of
chamomile to treat sleep disturbances.
The
authors acknowledge that the study had limitations—its short duration, it was
not double-blind, patients were not required to stop taking any
sedative-hypnotic medications during the trial, and it did not assess
individual sleep habits of the patients before the start of the trial. Despite
these limitations, the study indicates that chamomile offers a safe and
effective treatment for elderly people experiencing sleep disturbances.
—Heather B. Leach, MSc
|